|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,630,000,000 |
Market
Cap: |
384.35(B) |
Last
Volume: |
6,182,604 |
Avg
Vol: |
8,314,942 |
52
Week Range: |
$144.45 - $174.48 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
MAJOR MARKET |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 21 |
Guru Rank Value : 20.3 |
Guru Occurances : 6 |
|
|
|
|
|
|
|
Company Profile Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
68,288 |
68,288 |
115,451 |
522,170 |
Total Sell Value |
$10,723,734 |
$10,723,734 |
$18,652,688 |
$88,845,171 |
Total People Sold |
2 |
2 |
5 |
10 |
Total Sell Transactions |
2 |
2 |
5 |
24 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Decker Robert J |
VP Corporate Controller |
|
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
581 |
16,054 |
|
- |
|
Duato Joaquin |
CEO and Chairman of the Board |
|
2023-01-17 |
4 |
D |
$173.43 |
$17,134,017 |
D/D |
(98,795) |
295,720 |
|
- |
|
Duato Joaquin |
CEO and Chairman of the Board |
|
2023-01-17 |
4 |
OE |
$72.54 |
$10,774,947 |
D/D |
148,538 |
394,515 |
|
- |
|
Gorsky Alex |
Director |
|
2023-01-17 |
4 |
D |
$173.43 |
$63,581,172 |
D/D |
(366,610) |
766,584 |
|
- |
|
Gorsky Alex |
Director |
|
2023-01-17 |
4 |
OE |
$72.54 |
$39,729,578 |
D/D |
547,692 |
1,133,194 |
|
- |
|
Wolk Joseph J |
Exec VP, CFO |
|
2022-12-13 |
4 |
S |
$179.46 |
$2,654,661 |
D/D |
(14,781) |
35,812 |
|
8% |
|
Wolk Joseph J |
Exec VP, CFO |
|
2022-12-13 |
4 |
OE |
$72.54 |
$1,303,589 |
D/D |
14,781 |
50,593 |
|
- |
|
Mcevoy Ashley |
EVP, WW Chair, MedTech |
|
2022-11-30 |
4 |
S |
$175.46 |
$12,865,801 |
D/D |
(73,323) |
41,813 |
|
8% |
|
Mcevoy Ashley |
EVP, WW Chair, MedTech |
|
2022-11-30 |
4 |
OE |
$72.54 |
$5,318,850 |
D/D |
73,323 |
115,136 |
|
- |
|
Taubert Jennifer L |
EVP, WW Chair, Pharmaceuticals |
|
2022-11-22 |
4 |
S |
$176.78 |
$13,598,402 |
D/D |
(76,923) |
126,456 |
|
6% |
|
Taubert Jennifer L |
EVP, WW Chair, Pharmaceuticals |
|
2022-11-22 |
4 |
OE |
$72.54 |
$5,579,994 |
D/D |
76,923 |
203,379 |
|
- |
|
Decker Robert J |
Controller, CAO |
|
2022-11-18 |
4 |
S |
$175.00 |
$2,962,400 |
D/D |
(16,928) |
15,473 |
|
11% |
|
Decker Robert J |
Controller, CAO |
|
2022-11-18 |
4 |
OE |
$90.44 |
$1,530,968 |
D/D |
16,928 |
32,401 |
|
- |
|
Wengel Kathryn E |
EVP, Chief GSC Officer |
|
2022-11-09 |
4 |
S |
$173.42 |
$2,845,773 |
D/D |
(16,410) |
71,311 |
|
12% |
|
Wengel Kathryn E |
EVP, Chief GSC Officer |
|
2022-11-09 |
4 |
OE |
$72.54 |
$1,190,381 |
D/D |
16,410 |
87,721 |
|
- |
|
Mongon Thibaut |
Exec VP, WW Chair, Consumer |
|
2022-11-07 |
4 |
OE |
$101.87 |
$1,874,626 |
D/D |
17,043 |
57,176 |
|
- |
|
Mongon Thibaut |
Exec VP, WW Chair, Consumer |
|
2022-11-04 |
4 |
S |
$171.14 |
$6,033,305 |
D/D |
(35,246) |
40,133 |
|
10% |
|
Mongon Thibaut |
Exec VP, WW Chair, Consumer |
|
2022-11-04 |
4 |
OE |
$129.51 |
$4,609,161 |
D/D |
35,246 |
75,379 |
|
- |
|
Swanson James D. |
EVP, Chief Information Officer |
|
2022-11-02 |
4 |
D |
$172.29 |
$677,444 |
D/D |
(3,932) |
7,064 |
|
- |
|
Swanson James D. |
EVP, Chief Information Officer |
|
2022-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,912 |
10,996 |
|
- |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2022-10-24 |
4 |
S |
$170.76 |
$2,225,554 |
D/D |
(12,998) |
164,802 |
|
11% |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2022-10-24 |
4 |
S |
$170.76 |
$3,569,558 |
D/D |
(20,851) |
143,951 |
|
11% |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2022-10-24 |
4 |
S |
$170.76 |
$481,429 |
D/D |
(2,815) |
189,819 |
|
11% |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2022-10-24 |
4 |
OE |
$115.67 |
$9,075,237 |
D/D |
78,458 |
193,134 |
|
- |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2022-10-24 |
4 |
S |
$171.36 |
$5,016,623 |
D/D |
(29,275) |
114,676 |
|
11% |
|
162 Records found
|
|
Page 3 of 7 |
|
|